Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miR-196a enhances polymerization of neuronal microfilaments through suppressing IMP3 and upregulating IGF2 in Huntington's disease. | Mol Ther Nucleic Acids | 2022 | 36320323 | PubTator, text mining | PubMed |
| The role of non-coding RNA in the diagnosis and treatment of Helicobacter pylori-related gastric cancer, with a focus on inflammation and immune response. | Front Med (Lausanne) | 2022 | 36314013 | PubTator, text mining | PubMed |
| IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N6-methyladenosine-dependent binding. | Front Oncol | 2022 | 36313631 | PubTator, text mining | PubMed |
| Research progress of ginseng in the treatment of gastrointestinal cancers. | Front Pharmacol | 2022 | 36313365 | PubTator, text mining | PubMed |
| m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer. | J Transl Med | 2022 | 36309694 | PubTator, text mining | PubMed |
| RNA binding proteins in MLL-rearranged leukemia. | Exp Hematol Oncol | 2022 | 36307883 | PubTator, text mining | PubMed |
| Shikonin targets to m6A-modified oxidative damage pathway to alleviate benzene-induced testicular injury. | Food Chem Toxicol | 2022 | 36306860 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. | Cancer Cell | 2022 | 36306790 | PubTator, text mining | PubMed |
| Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma. | Front Oncol | 2022 | 36303829 | PubTator, text mining | PubMed |
| Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation. | Cell Death Dis | 2022 | 36302751 | PubTator, text mining | PubMed |
| ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36299451 | PubTator, text mining | PubMed |
| Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. | Pharmaceuticals (Basel) | 2022 | 36297381 | PubTator, text mining | PubMed |
| Chemical and Synthetic Biology Approaches for Cancer Vaccine Development. | Molecules | 2022 | 36296526 | PubTator, text mining | PubMed |
| The Diagnostic and Therapeutic Role of Circular RNA HIPK3 in Human Diseases. | Diagnostics (Basel) | 2022 | 36292157 | PubTator, text mining | PubMed |
| The Role of m6A Modification and m6A Regulators in Esophageal Cancer. | Cancers (Basel) | 2022 | 36291923 | PubTator, text mining | PubMed |
| The Role of N6-Methyladenosine Modification in Microvascular Dysfunction. | Cells | 2022 | 36291060 | PubTator, text mining | PubMed |
| Interplay between the m6A Epitranscriptome and Tumor Metabolism: Mechanisms and Therapeutic Implications. | Biomedicines | 2022 | 36289851 | PubTator, text mining | PubMed |
| METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. | Nat Commun | 2022 | 36289222 | PubTator, text mining | PubMed |
| IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma. | Biosci Rep | 2022 | 36281789 | PubTator, text mining | PubMed |
| Investigation of the biomarkers involved in ectopic ossification: The shared mechanism in ossification of the spinal ligament. | Front Genet | 2022 | 36276940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=50